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margin status), more aggressive surgery and increasing use of
radiotherapy.
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Background: The aim of our study was to assess various
risk factors for local recurrence (LR) in patients undergoing
breast conservation surgery (BCS) for ductal carcinoma
in situ (DCIS).
Materials and methods: Retrospective case note review
between January 1975 and June 2008. In our hospital a margin
of P10 mm is considered acceptable. Patients were divided into
three groups based on pathological margin (<5 mm, 5–9 mm
and P10 mm). Cox regression model for multivariate analysis
of local recurrence was used with variables with significant P
values (<0.05) in the univariate analysis carried out using SPSS
version 16.
Results: Overall 239 women had BCS for DCIS during the above
period. The median age was 59 years (40–86) and the median fol-
low-up was 76 months (1–308). Pathological findings included
median size of 11 mm (1–50), 75 cases with comedo necrosis
and 5 patients with microinvasion (<1 mm). Overall 193 patients
had grades recorded (44 low grade, 54 intermediate grade and
95 high grade).
Overall LR rate was 17% (40/239), of which 65% (26/40) were
invasive recurrences. Thirty-one patients were 6 to 50 years
and 32% (10/31) developed LR compared to 14% (30/208) in
those above 50 years (P = 0.018). Forty-three percent of patients
(6/14) with <5 mm margin developed LR compared to 12% (3/
25) with 5–9 mm margin and 14% (27/188) with P10 mm mar-
gin. Four out of 12 patients with unknown margin status
developed LR. The LR rate in patients with <5 mm (6/14) mar-
gin was significantly higher compared to those with P5 mm
(30/213) margin (P value < 0.012). Three out of 5 patients with
microinvasion developed LR and it was statistically significant
(P = 0.034) compared to those without microinvasion. On multi-
variate analysis age 650 years, <5 mm pathological margin and
microinvasion were independent poor prognostic factors for
local recurrence.
Conclusion: Our study shows that younger age (650 years), a
clear margin <5 mm and associated microinvasion are poor prog-
nostic factors for LR in patients undergoing breast conservation
surgery for DCIS.
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Introduction: Tumour specific mRNA markers detected by real
time reverse transcriptase-polymerase chain reaction (RT-PCR)
have been used to detect breast cancer metastases in sentinel
lymph nodes. We present our experience of 500 consecutive cases
in a single centre.
Methods: All clinically and radiologically node negative
patients who underwent sentinel node biopsy (SLNB) were
included in the study over a 24-month period. SLNB was per-
formed according to New Start guidelines. Intraoperative anal-
ysis was performed on alternate slices at 2 mm intervals,
with the remaining slices sent for standard histological anal-
ysis. The GeneSearch assay (Veridex LLC, Warren, NJ) was
used to detect the expression of mammaglobin (MG) and
cytokeratin 19 (CK). Patients were considered SLNB positive
if one or more sentinel lymph nodes were positive for either
MG or CK.
Results: Sentinel lymph nodes (912) were analysed with an
average of 1.8 nodes per patient. The cohort was representative
Table 1
Time period 1988–1993 (n. 300) 1994–1997 (n. 319) 2000–2003 (n. 547)
Non-operative diagnosis 59 (20%) 142 (45%) 439 (80%)
Treatment
Mastectomy 134 (45%) 127 (40%) 205 (37%)
Wide local excision 123 (41%) 141 (44%) 294 (54%)
Diagnostic excision alone 43 (14%) 51 (16%) 48 (9%)
Radiotherapy (post conservation) 24 (15%) 25 (13%) 186 (54%)
Tamoxifen 139 (46%) 149 (47%) 240 (44%)
5 year LRR
Mastectomy 2 (1.5%) 3 (2.5%) 1 (0.5%)
Wide local excision 12 (10%) 17 (12%) 19 (6.5%)
Diagnostic excision alone 9 (22%) 6 (12%) 1 (2%)
22 EJC SUPPLEMENTS 8 (2010) 1–36
